The Enterprise Value as of September 2024 (TTM) for Eton Pharmaceuticals, Inc. (ETON) is 130.30M

According to Eton Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 130.30M. This represents a change of 49.91% compared to the average of 86.92M of the last 4 quarters.

Eton Pharmaceuticals, Inc. (ETON) Historical Enterprise Value (quarterly & annually)

How has ETON Enterprise Value performed in the past?

The mean historical Enterprise Value of Eton Pharmaceuticals, Inc. over the last ten years is 91.93M. The current 130.30M Enterprise Value has changed 14.07% with respect to the historical average. Over the past ten years (40 quarters), ETON's Enterprise Value was at its highest in in the December 2020 quarter at 179.41M. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.

Eton Pharmaceuticals, Inc. (ETON) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Eton Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Eton Pharmaceuticals, Inc. (ETON) Average Enterprise Value

How has ETON Enterprise Value performed in the past?

The current Enterprise Value of Eton Pharmaceuticals, Inc. (ETON) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Eton Pharmaceuticals, Inc. (ETON) Enterprise Value vs. Peers

How is ETON’s Enterprise Value compared to its peers?

Eton Pharmaceuticals, Inc.’s Enterprise Value is greater than Connect Biopharma Holdings Limited (-39789702.00), greater than Acumen Pharmaceuticals, Inc. (112.86M), less than Nuvation Bio Inc. (1.01B), greater than Eledon Pharmaceuticals, Inc. (76.53M), less than Eliem Therapeutics, Inc. (330.54M), greater than Inhibrx, Inc. (30.52M), greater than Merrimack Pharmaceuticals, Inc. (-10189682.00), less than Celcuity Inc. (625.21M), less than Enliven Therapeutics, Inc. (959.94M), less than Replimune Group, Inc. (635.52M), greater than Nuvectis Pharma, Inc. (95.85M), greater than Lyra Therapeutics, Inc. (23.17M), greater than Kronos Bio, Inc. (12.94M), less than Gossamer Bio, Inc. (317.96M), less than Tarsus Pharmaceuticals, Inc. (1.11B), greater than LianBio (-66141903.00), less than Aldeyra Therapeutics, Inc. (339.35M), less than Travere Therapeutics, Inc. (1.48B), greater than Passage Bio, Inc. (47.09M), less than Black Diamond Therapeutics, Inc. (302.88M), greater than TCR2 Therapeutics Inc. (49.64M), less than Harpoon Therapeutics, Inc. (861.85M), less than Alector, Inc. (554.98M),

Build a custom stock screener for Eton Pharmaceuticals, Inc. (ETON) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eton Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eton Pharmaceuticals, Inc. (ETON) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eton Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.